SCHEDULE: Orbis, Allan Gray Disclose 6.6% Stake in Genmab A/S

Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd jointly reported a 6.6% beneficial ownership stake in Genmab A/S common stock.

Summary

• Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd collectively hold 4,237,472 shares of Genmab A/S Common Stock.
• This aggregate ownership represents 6.6% of the total class of securities.
• Orbis Investment Management Ltd beneficially owns 4,229,662 shares, comprising 2,791,155 Common Stock and 1,438,507 Common Stock represented by American Depositary Receipts.
• Allan Gray Australia Pty Ltd beneficially owns 7,810 shares, comprising 4,471 Common Stock and 3,339 Common Stock represented by American Depositary Receipts.
• The reporting persons are classified as Non-U.S. Institutions equivalent to Investment Advisers.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a standard regulatory disclosure of beneficial ownership and does not contain information related to the issuer's operational performance or strategic direction.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which can influence market perception and trading activity.

Key Dates

Keywords

Genmab A/S, Orbis Investment Management, Allan Gray Australia, Beneficial Ownership, Schedule 13G, Common Stock, ADR, Investment Adviser, Institutional Ownership